Hims & Hers Health (HIMS) Enterprise Value (2019 - 2026)
Hims & Hers Health's (HIMS) quarterly Enterprise Value came in at -$750.9 million in Q1 2026, down 132.71% year-on-year from $2.3 billion in Q1 2025, and down 30.02% quarter-over-quarter from -$577.5 million in Q4 2025.
Hims & Hers Health (HIMS) Enterprise Value (2019 - 2026) Analysis & Trends
Hims & Hers Health has disclosed Enterprise Value across 8 years of filings, most recently posting -$750.9 million for Q1 2026.
- Enterprise Value for Q1 2026 came in at -$750.9 million, down 132.71% year-over-year; the trailing twelve-month figure through Mar 2026 was -$750.9 million (down 132.71% YoY), and the FY2025 annual result was -$577.5 million, down 92.34% from the prior year.
- Enterprise Value came in at -$750.9 million for Q1 2026 at Hims & Hers Health, down from -$577.5 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$179.6 million in Q4 2022 to a low of -$1.1 billion in Q2 2025.
- The 5-year median for Enterprise Value is -$221.0 million (2023), against an average of -$352.8 million.
- Across the five-year window, Enterprise Value surged 38.56% in 2022 and tumbled 403.59% in 2025, its largest moves.
- Hims & Hers Health's Enterprise Value stood at -$179.6 million in 2022, then retreated by 23.02% to -$221.0 million in 2023, then tumbled by 35.87% to -$300.3 million in 2024, then sank by 92.34% to -$577.5 million in 2025, then slumped by 30.02% to -$750.9 million in 2026.
- The last three Enterprise Value figures came in at -$750.9 million (Q1 2026), -$577.5 million (Q4 2025), and -$629.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -3.74 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -1.94 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -2.15 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -77.77 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -1.32 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -428.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -511.86 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -498.58 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -750.88 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | -222.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -750.88 Mn |
| Dec 31, 2025 | -577.49 Mn |
| Sep 30, 2025 | -629.74 Mn |
| Jun 30, 2025 | -1.14 Bn |
| Mar 31, 2025 | -322.67 Mn |
| Dec 31, 2024 | -300.25 Mn |
| Sep 30, 2024 | -254.07 Mn |
| Jun 30, 2024 | -227.29 Mn |
| Mar 31, 2024 | -203.59 Mn |
| Dec 31, 2023 | -220.98 Mn |
| Sep 30, 2023 | -212.50 Mn |
| Jun 30, 2023 | -193.14 Mn |
| Mar 31, 2023 | -184.39 Mn |
| Dec 31, 2022 | -179.63 Mn |
| Sep 30, 2022 | -198.39 Mn |
| Jun 30, 2022 | -194.98 Mn |
| Mar 31, 2022 | -203.05 Mn |
| Dec 31, 2021 | -247.27 Mn |
| Sep 30, 2021 | -252.43 Mn |
| Jun 30, 2021 | -317.32 Mn |